TINA CHEMPLAYIL: Open Payments
NPI 1801312780 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 22 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $235 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $172 |
| Janssen Biotech, Inc. | 3 | $171 |
| Medtronic, Inc. | 5 | $96 |
| ConvaTec Inc. | 1 | $59 |
| UROGEN PHARMA, INC. | 3 | $57 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Endo USA, Inc. | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $21 |
Products named: GEMTESA, RYBREVANT, INTERSTIM, GENTLECATH GLIDE, ERLEADA, KEYTRUDA, XIAFLEX, APTIMA.
Industry payments across PA — which companies pay providers there.
